About Richard Meyer

Passionate, award-winning Marketing and Media Executive with an MBA and 15+ years success implementing cutting-edge strategies. Career highlights include driving development/launch of a groundbreaking e-Marketing branding initiative for Eli Lilly product Cialis that led to Website becoming #1 online pharma destination (and #1 in prescription conversions), increasing leads 30% and ROI 38% for $1B manufacturer Medtronic

Healthcare: Americans are paying more for less

  • The American healthcare system is a hellish tangle of bureaucracy, with various  inefficiencies and injustices.
  • A sensible healthcare system would have done something about for-profit drug companies who continually raise prices.
  • America already pays enough to fund two generous universal healthcare systems for its citizenry.

Continue reading

The poor reliability of online health information

  • Many popular YouTube videos about prostate cancer contained biased or poor-quality information.
  • There was a significant negative correlation between scientific quality and viewer engagement.
  • The comments section underneath some videos contained advertising and peer-to-peer medical advice.
  • A total of 115 videos (77%) contained potentially misinformative and/or biased content within the video or comments section, with a total reach of >6 million viewers.
  • For online health seekers there is too much invalid health information and they are pretty much left to determine what’s based on medical knowledge and what’s garbage.

Continue reading

Office visits to primary care physicians declined 18 percent

  • Office visits to nurse practitioners (NPs) and physician assistants (PAs) increased 129 percent.
  • Office visits to primary care physicians (PCPs) declined 18 percent from 2012 to 2016 for adults under 65 years old with employer-sponsored health insurance.
  • From 2012 to 2016, office visits to NPs and PAs increased each year.

Continue reading

The focus on drug prices ignores the real issue for healthcare costs

  • The overall diabetes rate in the U.S. adult population is growing, up from 10.8% in 2008-2009 to 11.5% in 2016-2017.
  • The rate increase has resulted in about 1.7 million more Americans with diabetes diagnoses now than would have been the case had the rate not changed since 2008-2009.
  • Even more alarming is that obesity, a key risk factor in the development of type 2 diabetes, has climbed by 2.3 points since 2008-2009, to reach 28.3% nationally in 2016-2017.

Continue reading

How is Pfizer employee morale?

  • 41 of Pfizer’s drugs have been picked for a price hike on January 15, averaging 5%.
  • Pfizer noted Friday that the increases will be offset by higher rebates and discounts offered to insurance companies and pharmacy benefit managers.
  • Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.

Continue reading

How to screw up a clinical trial

  • Amarin’s clinical trial of fish oil may be tainted because of suspicions that the placebo group received mineral oil which could affect the absorption of statins. This “anti-statin” effect could raise “bad cholesterol” levels, enhancing the separation of major adverse cardiac events (MACE) between Vascepa and control.
  • Cardiologists who reviewed the data see a big problem with the study that could mean that it exaggerates Vascepa’s benefits.
  • Mineral oil may not not behaved as a placebo at all.
  • Will insurers recommend OTC fish oil?

Continue reading